Iproheptine

Last updated

Iproheptine
Iproheptine.png
Clinical data
Trade names Metron, Susat
Other namesN-Isopropyl-1,5-dimethylhexylamine; N-Isopropyloctodrine
Identifiers
  • 6-methyl-N-propan-2-ylheptan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.034.283 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C11H25N
Molar mass 171.328 g·mol−1
3D model (JSmol)
  • CC(C)CCCC(C)NC(C)C
  • InChI=1S/C11H25N/c1-9(2)7-6-8-11(5)12-10(3)4/h9-12H,6-8H2,1-5H3 Yes check.svgY
  • Key:NKGYBXHAQAKSSG-UHFFFAOYSA-N Yes check.svgY

Iproheptine, also known as N-isopropyl-1,5-dimethylhexylamine or N-isopropyloctodrine and sold under the brand names Metron and Susat, is a nasal decongestant which has been marketed in Japan. [1] [2] [3] It is described as a vasoconstrictor and antihistamine. [1] [2] [3] The drug is available over-the-counter in Japan. [4]

Contents

Pharmacology

Pharmacodynamics

Iproheptine is described as a decongestant, vasoconstrictor, and antihistamine. [1] [2] [3] Its pharmacology was characterized in a series of several preclinical studies published in the 1960s. [5] [6] [7] [8] [9] [10]

The drug was found to have anticholinergic- and antihistamine-like effects that were described as more potent than those of ephedrine. [6] [8] [10] It was said to have hypotensive and cardiac inhibitive actions that made it differ from other known alkylamine and arylalkylamine sympathomimetics. [6] [8] The effects of iproheptine on blood vessels, pupils, and saliva secretion were all said to be very weak. [6] It produced bronchodilation, vasoconstriction, and hemostasis similarly to ephedrine or methoxyphenamine. [7] [10] Iproheptine showed no effect against hexobarbital-induced sleep. [7] Conversely, it showed an antidepressant- or stimulant-like effect in the forced swim test (FST). [9]

Close analogues of iproheptine, such as methylhexanamine and tuaminoheptane, are known to act as norepinephrine and/or dopamine releasing agents by interacting with the monoamine transporters, and this is thought to underlie their sympathomimetic and stimulant effects. [11] [12] [13] [14] [15] [16]

Pharmacokinetics

In contrast to arylalkylamines like phenethylamines and tryptamines, iproheptine is not metabolized by monoamine oxidase (MAO). [9]

Chemistry

Iproheptine, also known as N-isopropyl-1,5-dimethylhexylamine or as N-isopropyloctodrine, is an alkylamine and the N-isopropyl derivative of octodrine (2-amino-6-methylheptane or 1,5-dimethylhexylamine (1,5-DMHA)). [1] [2] [3]

Aside from octodrine, it is also closely structurally related to other alkylamines, including 1,3-dimethylbutylamine (1,3-DMBA), 1,4-dimethylamylamine (1,4-DMAA), heptaminol (2-methyl-6-amino-2-heptanol), isometheptene (2-methyl-6-methylamino-2-heptene), methylhexanamine (1,3-dimethylamylamine (1,3-DMAA)), and tuaminoheptane (tuamine; 2-aminoheptane or 1-methylhexylamine). [1] [2] [3]

Iproheptine shows structural similarity to what would be 3- or 4-methyl-N-isopropylamphetamine, but with the equivalent of the phenyl ring open and incomplete (i.e., missing two carbon atoms, saturated, and the carbons not connected to form a ring). [17] [1]

The predicted log P (XLogP3) of iproheptine is 3.6. [17]

History

Iproheptine was first described in the scientific literature by 1960 [5] [6] and was first patented by 1962. [1] It remained marketed in Japan in 2004. [2]

Society and culture

Names

Iproheptine is the generic name of the drug and its INN Tooltip International Nonproprietary Name. [1] [2] In the case of the hydrochloride salt, its generic name is iproheptine hydrochloride and this is its JAN Tooltip Japanese Accepted Name. [2] The drug is marketed under the brand names Metron and Susat (both as the hydrochloride salt). [1] [2]

Availability

Iproheptine appears to have been marketed only in Japan. [2] It is available over-the-counter in this country. [4]

See also

Related Research Articles

<span class="mw-page-title-main">Butylone</span> Entactogen, psychedelic, and stimulant drug of the phenethylamine class

Butylone, also known as β-keto-N-methylbenzodioxolylbutanamine (βk-MBDB), is an entactogen, psychedelic, and stimulant psychoactive drug of the phenethylamine, amphetamine, phenylisobutylamine, and cathinone families. It is the β-keto analogue of MBDB and the substituted methylenedioxyphenethylamine analogue of buphedrone.

<span class="mw-page-title-main">Isometheptene</span> Sympathomimetic amine

Isometheptene is a sympathomimetic amine sometimes used in the treatment of migraines and tension headaches due to its vasoconstricting properties; that is, it causes constriction (narrowing) of blood vessels. Along with paracetamol and dichloralphenazone, it is one of the constituents of Amidrine.

<span class="mw-page-title-main">ETH-LAD</span> Chemical compound

ETH-LAD, 6-ethyl-6-nor-lysergic acid diethylamide is an analogue of LSD. Its human psychopharmacology was first described by Alexander Shulgin in the book TiHKAL. ETH-LAD is a psychedelic drug similar to LSD, and is slightly more potent than LSD itself, with an active dose reported at between 20 and 150 micrograms. ETH-LAD has subtly different effects to LSD, described as less demanding.

<span class="mw-page-title-main">PRO-LAD</span> Chemical compound

PRO-LAD is an analogue of LSD. It is described by Alexander Shulgin in the book TiHKAL. PRO-LAD is a psychedelic drug similar to LSD, and is around as potent as LSD itself with an active dose reported at between 100 and 200 micrograms.

<span class="mw-page-title-main">Butenafine</span> Chemical compound

Butenafine, sold under the brand names Lotrimin Ultra, Mentax, and Butop, is a synthetic benzylamine derived antifungal drug.

<span class="mw-page-title-main">Cloperastine</span> Chemical compound

Cloperastine (INN) or cloperastin, in the forms of cloperastine hydrochloride (JAN) and cloperastine fendizoate, is an antitussive and antihistamine that is marketed as a cough suppressant in Japan, Hong Kong, and in some European countries. It was first introduced in 1972 in Japan, and then in Italy in 1981.

<span class="mw-page-title-main">Tuaminoheptane</span> Sympathomimetic agent

Tuaminoheptane is a sympathomimetic agent and vasoconstrictor which was formerly used as a nasal decongestant. It is still used in France as a nasal decongestant but its use is not recommended by the health authorities due to the lack of evidence of its effectiveness. It has also been used as a stimulant.

<span class="mw-page-title-main">Flutazolam</span> Benzodiazepam

Flutazolam is a drug which is a benzodiazepine derivative. It was invented in Japan, and this is the main country in which it has been used medically. It has sedative, muscle relaxant, anticonvulsant, and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and though it is around the same potency as diazepam, it produces a more marked sedation and impaired coordination. It is indicated for the treatment of insomnia. Its major active metabolite is n-desalkylflurazepam, also known as norflurazepam, which is also a principal metabolite of flurazepam. While flutazolam has a very short half-life of only 3.5 hours, n-desalkylflurazepam has a long half-life of between 47–100 hours.

<span class="mw-page-title-main">Rilmazafone</span> Chemical compound

Rilmazafone is a water-soluble prodrug developed in Japan. Inside the human body, rilmazafone is converted into several benzodiazepine metabolites that have sedative and hypnotic effects.

<span class="mw-page-title-main">Methylhexanamine</span> Chemical compound

Methylhexanamine is an indirect sympathomimetic drug invented and developed by Eli Lilly and Company and marketed as an inhaled nasal decongestant from 1948 until it was voluntarily withdrawn from the market in the 1980s.

<span class="mw-page-title-main">Phenpromethamine</span> Sympathomimetic nasal decongestant (Phenethylamine group)

Phenpromethamine, also known as N,β-dimethylphenethylamine, is a sympathomimetic nasal decongestant of the phenethylamine group. It was previously marketed as a nasal inhaler from 1943 through 1960 but is no longer available. The medication is a stimulant and is banned by the World Anti-Doping Agency. It has been detected in dietary supplements starting in the 2010s.

<span class="mw-page-title-main">Octodrine</span> DMAA substitute

Octodrine, also known as dimethylhexylamine (DMHA) and sold under the brand name Vaporpac among others, is a sympathomimetic and stimulant medication that was formerly used in the treatment of hypotension.

<span class="mw-page-title-main">Alpinetin</span> Chemical compound

Alpinetin is a phytochemical isolated from a variety of plants including those of the genus Alpinia. It is going through tests to see if it is a vasorelaxant.

<span class="mw-page-title-main">Teniloxazine</span> Chemical compound

Teniloxazine, also known as sufoxazine and sulfoxazine, is a drug which is marketed in Japan. Though initially investigated as a neuroprotective and nootropic agent for the treatment of cerebrovascular insufficiency in the 1980s, it was ultimately developed and approved as an antidepressant instead. It acts as a potent norepinephrine reuptake inhibitor, with fair selectivity over the serotonin and dopamine transporters, and also behaves as an antagonist of the 5-HT2A receptor.

<span class="mw-page-title-main">Friedelin</span> Chemical compound

Friedelin is a triterpenoid chemical compound found in Azima tetracantha, Orostachys japonica, and Quercus stenophylla. Friedelin is also found in the roots of the Cannabis plant.

<span class="mw-page-title-main">Furonazide</span> Chemical compound

Furonazide is a crystalline tuberculostatic drug substance with a reported melting point of 199-201.5 °C.

<span class="mw-page-title-main">1,3-Dimethylbutylamine</span> Chemical compound

1,3-Dimethylbutylamine, is a stimulant drug structurally related to methylhexanamine where a butyl group replaces the pentyl group. The compound is an aliphatic amine.

<span class="mw-page-title-main">Filicin</span> Chemical compound

Filicin is a chemical compound that has been isolated from ferns of the genus Dryopteris. It has been isolated from the male fern. Filicin has been studied for its anthelmintic activity.

<span class="mw-page-title-main">Gestonorone acetate</span> Chemical compound

Gestonorone acetate, or gestronol acetate, also known as norhydroxyprogesterone acetate, is a progestin of the 19-norprogesterone and 17α-hydroxyprogesterone groups which was developed in the early 1960s but was never marketed. It is the C17α acetate ester of gestronol (17α-hydroxy-19-norprogesterone).

References

  1. 1 2 3 4 5 6 7 8 9 Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 802. ISBN   978-1-4757-2085-3 . Retrieved 30 August 2024.
  2. 1 2 3 4 5 6 7 8 9 10 Schweizerischer Apotheker-Verein (2004). Index Nominum: International Drug Directory. Index Nominum: International Drug Directory. Medpharm Scientific Publishers. p. 656. ISBN   978-3-88763-101-7 . Retrieved 30 August 2024.
  3. 1 2 3 4 5 Milne GW (2018). Drugs: Synonyms and Properties. Routledge Revivals. Taylor & Francis. p. 286. ISBN   978-1-351-78990-5 . Retrieved 30 August 2024. Iproheptine 13946-02-6 6243 CHAN N-Isopropyl-1,5-dimethylhexylamine. Metron; Metron S. Antihistaminic.
  4. 1 2 "KEGG DRUG: Iproheptine Hydrochloride". GenomeNet. Retrieved 30 August 2024.
  5. 1 2 Ota Y, Otani G, Enomoto R (1960). "Pharmacological Studies on Alkylaminoheptane Derivatives. I: Tracheal Muscle Spasmolytic Action of N-Alkyl-1, 5-dimethylhexylamine Derivatives". Yakugaku Zasshi. 80 (9): 1153–1155. doi: 10.1248/yakushi1947.80.9_1153 . ISSN   0031-6903.
  6. 1 2 3 4 5 Ota Y, Enomoto R, Ishiguro Y (1960). "Pharmacological Studies on Alkylaminoheptane Derivatives. II: Pharmacological Action of N-Isopropyl-1, 5-dimethylhexylamine Hydrochloride. (1)". Yakugaku Zasshi. 80 (9): 1156–1159. doi: 10.1248/yakushi1947.80.9_1156 . ISSN   0031-6903.
  7. 1 2 3 Ota Y, Fuchibe K, Takahashi M (1961). "Pharmacological Studies on Alkylaminoheptane Derivatives. III: Pharmacological Action of N-Isopropyl-1, 5-dimethylhexylamine Hydrochloride. (2)". Yakugaku Zasshi. 81 (3): 394–402. doi: 10.1248/yakushi1947.81.3_394 . ISSN   0031-6903.
  8. 1 2 3 Ota Y (1961). "Pharmacological Studies on Alkylaminoheptane Derivatives. IV: Blood Pressor, Antispasmodic and Capillary Permeability Inhibiting Action of N-Alkyl-1, 5-dimethylhexylamine Derivatives". Yakugaku Zasshi. 81 (3): 403–407. doi: 10.1248/yakushi1947.81.3_403 . ISSN   0031-6903.
  9. 1 2 3 Ota Y, Watabe M, Takahashi M (1961). "Pharmacological Studies on Alkylaminoheptane Derivatives. V: Pharmacological Action of N-isopropyl-1, 5-dimethylhexylamine Hydrochloride. (3)". Yakugaku Zasshi. 81 (3): 407–414. doi: 10.1248/yakushi1947.81.3_407 . ISSN   0031-6903.
  10. 1 2 3 Ota Y (1961). "Pharmacological Studies on Alkylaminoheptane Derivatives. VI: Pharmacological Action of N-Isopropyl-1, 5-dimethyl-hexylamine Hydrochloride. (4)". Yakugaku Zasshi. 81 (3): 415–420. doi: 10.1248/yakushi1947.81.3_415 . ISSN   0031-6903.
  11. ↑ Small C, Cheng MH, Belay SS, Bulloch SL, Zimmerman B, Sorkin A, et al. (August 2023). "The Alkylamine Stimulant 1,3-Dimethylamylamine Exhibits Substrate-Like Regulation of Dopamine Transporter Function and Localization". J Pharmacol Exp Ther. 386 (2): 266–273. doi:10.1124/jpet.122.001573. PMC   10353075 . PMID   37348963.
  12. ↑ Docherty JR (June 2008). "Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)". Br J Pharmacol. 154 (3): 606–622. doi:10.1038/bjp.2008.124. PMC   2439527 . PMID   18500382.
  13. ↑ Delicado EG, Fideu MD, Miras-Portugal MT, Pourrias B, Aunis D (August 1990). "Effect of tuamine, heptaminol and two analogues on uptake and release of catecholamines in cultured chromaffin cells". Biochem Pharmacol. 40 (4): 821–825. doi:10.1016/0006-2952(90)90322-c. PMID   2386550.
  14. ↑ Alsufyani HA, Docherty JR (January 2019). "Methylhexaneamine causes tachycardia and pressor responses indirectly by releasing noradrenaline in the rat". Eur J Pharmacol. 843: 121–125. doi:10.1016/j.ejphar.2018.10.047. PMID   30395850.
  15. ↑ Schlessinger A, Geier E, Fan H, Irwin JJ, Shoichet BK, Giacomini KM, et al. (September 2011). "Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET". Proc Natl Acad Sci U S A. 108 (38): 15810–15815. doi:10.1073/pnas.1106030108. PMC   3179104 . PMID   21885739.
  16. ↑ Rickli A, Hoener MC, Liechti ME (September 2019). "Pharmacological profiles of compounds in preworkout supplements ("boosters")". Eur J Pharmacol. 859: 172515. doi:10.1016/j.ejphar.2019.172515. PMID   31265842.
  17. 1 2 "Iproheptine". PubChem. Retrieved 8 December 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.